Sfoglia per Rivista  HAEMATOLOGICA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 140 a 159 di 266
Titolo Data di pubblicazione Autore(i) File
L'interferone nel trattamento della leucemia mieloide cronica Philadelphia positiva. 1990 Morra, E; Alimena, G; Lazzarino, M; Liberati, Anna Marina; Montefusco, E; Inverardi, D; Bernasconi, P; Mancini, M; Donti, Emilio; Senatore, M; Dianzani, F.; Grignani, F.; Bernasconi, C; Mandelli, F.
Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry. 2007 Giannini, Silvia; Mezzasoma, Anna Maria; Leone, Mario; Gresele, Paolo
Laparoscopic splenectomy in the management of hematological diseases. 1995 Silvestri, F; Russo, D; Fanin, R; Virgolini, L; Terrosu, G; Donini, Annibale; Bresadola, F; Baccarani, M.
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability. 2009 Meloni, G.; Mancini, M.; Gianfelici, V.; Martelli, Maria Paola; Foa, R.; Falini, Brunangelo
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability. 2008 Meloni, G; Mancini, M; Gianfelici, V; Martelli, Maria Paola; Foa, R; B., Falini
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi. 2013 Chiappella, A; Tucci, A; Castellino, A; Pavone, V; Baldi, I; Carella, Am; Orsucci, L; Zanni, M; Salvi, F; Liberati, Anna Marina; Gaidano, G; Bottelli, C; Rossini, B; Perticone, S; De Masi, P; Ladetto, M; Ciccone, G; Palumbo, A; Rossi, G; Vitolo, U.
Leukocyte-endothelial cell interactions and vascular injury in the earliest preclinical stages of atherosclerosis 1997 Lombardini, R; Vaudo, Gaetano; Ciuffetti, G.
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease 2004 Marafiori, T.; Mancini, C.; Ascani, Stefano; Sabattini, E.; Zinzani, P. L.; Pozzobon, M.; Pulford, K.; Falini, Brunangelo; Jaffe, E.; Muller Hermelink, H.; Mason, D.; Pileri, S.
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 2004 Iorio, Alfonso; Ferrante, F.; Conti, S.; Nenci, Giuseppe Giorgio
Long non-coding RNA expression profile in cytogenetically normal acute myeloid leukemia identifies a distinct signature and a new biomarker in NPM1-mutated patients 2017 De Clara, Etienne; Gourvest, Morgane; Ma, Hanjing; Vergez, François; Tosolini, Marie; Dejean, Sébastien; Demur, Cécile; Delabesse, Eric; Recher, Christian; Touriol, Christian; Martelli, Maria Paola; Falini, Brunangelo; Brousset, Pierre; Bousquet, Marina
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up. 2009 Palandri, ; Castagnetti, F; Alimena, G; Testoni, N; Breccia, M; Luatti, S; Rege Cambrin, G; Stagno, F; Specchia, G; Martino, B; Levato, L; Merante, S; Liberati, Anna Marina; Pane, F; Saglio, G; Alberti, D; Martinelli, G; Baccarani, M; Rosti, G.
Long-term Outcome of 309 Young Patients With Untreated Diffuse Large B-cell Lymphoma (dlbcl) At Poor Prognosis: A Pooled Analysis From Gimurell and Intergruppo Italiano Linfomi (iil) 2010 A., Chiappella; M. G., Cabras; Liberati, Anna Marina; E., Angelucci; L., Baldini; C., Bottelli; B., Botto; N., Cascavilla; G., Ciccone; S., Cortelazzo; P. D., Masi; L., Falchi; G., Fioritoni; C., Frairia; R., Freilone; A., Levis; L., Orsucci; C., Parvis; E., Pogliani; D., Rota Scalabrini; F., Salvi; G., Specchia; A., Tonso; A., Tucci; U., Vitolo
Low molecular weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis 2000 Iorio, Alfonso; Agnelli, G.
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 2001 Momi, Stefania; Nasimi, M.; Colucci, M.; Nenci, Giuseppe Giorgio; Gresele, Paolo
Low-molecular-weight heparin and cancer survival: pooled analysis of 1726 patients treated for three months 2004 Guercini, F.; Conti, S.; Iorio, Alfonso
Low-molecular-weight heparin treatment and cancer: pooled analysis of 908 patients treated for three months 2002 Guercini, F.; Pini, M.; Iorio, Alfonso
Low-molecular-weight-heparin for the long term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparison with oral anticoagulant 2002 Iorio, Alfonso; Guercini, F.; Pini, M.
Lymphoplasmacytic lymphoma and marginal zone lymphoma: diagnostic challenges 2005 Pileri, S.; Zinzani, P.; Sabattini, E.; Falini, Brunangelo
Mantle cell lymphoma. 2009 Pileri, S.; Falini, Brunangelo
Mechanisms of thrombocytopenia in platelet-type von Willebrand disease 2019 Bury, Loredana; Malara, Alessandro; Momi, Stefania; Petito, Eleonora; Balduini, Alessandra; Gresele, Paolo
Mostrati risultati da 140 a 159 di 266
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile